Sarepta Therapeutics (SRPT)

Sarepta Therapeutics (SRPT)

Postby winston » Tue Jun 24, 2014 4:54 am

not vested

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases.

Its lead product candidate is Eteplirsen, an antisense PMO-based therapeutic in clinical development for the treatment of individuals with Duchenne muscular dystrophy.

The company is also involved in developing treatments that are in clinical development include AVI-7288 for the treatment of Marburg virus and AVI-7100 for the treatment of influenza.

In addition, it focuses on developing preclinical research product candidates for the treatment of other neuromuscular, infectious, and rare diseases.

http://todaysbigstock.com/2014/06/23/sa ... aq-srpt-2/
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Return to S to Z

Who is online

Users browsing this forum: No registered users and 11 guests

cron